ホーム > 末原泰人/ SUEHARA, Yasuhito

末原泰人

SUEHARA, Yasuhito

医学医療系　血液内科 , 講師
Department of Hematology, Institute of Medicine

オープンアクセス版の論文は「つくばリポジトリ」で読むことができます。

41. Liquid biopsy for the identification of intravascular large B-cell lymphoma. Yasuhito Suehara; Mamiko Sakata-Yanagimoto; Keiichiro Hattori; Toru Nanmoku (+18 著者) Shigeru Chiba
Haematologica 103: e241-e244 (2018) Semantic Scholar
42. Droplet digital polymerase chain reaction assay and peptide nucleic acid-locked nucleic acid clamp method for RHOA mutation detection in angioimmunoblastic T-cell lymphoma Sharna Tanzima Nuhat; Mamiko Sakata-Yanagimoto; Daisuke Komori; Keiichiro Hattori (+7 著者) Shigeru Chiba
Cancer Science 109: 1682 (2018) Semantic Scholar
43. Clinical significance of disease-specific MYD88 mutations in circulating DNA in primary central nervous system lymphoma. Keiichiro Hattori; Mamiko Sakata-Yanagimoto; Yasuhito Suehara; Yasuhisa Yokoyama (+8 著者) Shigeru Chiba
Cancer science 109: 225 (2018) Semantic Scholar
44. Clinical significance of disease-specific MYD88 mutations in circulating DNA in primary central nervous system lymphoma. Keiichiro Hattori; Mamiko Sakata-Yanagimoto; Yasuhito Suehara; Yasuhisa Yokoyama (+8 著者) Shigeru Chiba
Cancer science 109: 225 (2018) Semantic Scholar
45. 骨髄異形成症候群の臨床像と体細胞遺伝子変異との関連平沢伸広; 小川誠司; 長谷川雄一; 千葉滋 (+7 著者) 小原直
Rinsho Ketsueki 59: 80 (2018) Semantic Scholar
46. 初発時と全身再発時のPCNSLの遺伝子異常の比較による、common precursor cellの存在の確認服部圭一朗; 坂田麻実子[柳元]; 末原泰人; 横山泰久 (+4 著者) 千葉滋
日本癌学会総会記事 76回: J (2017)
47. Quantification of bone marrow plasma cell infiltration in multiple myeloma: usefulness of bone marrow aspirate clot with CD138 immunohistochemistry Kosei Matsue; Yuya Matsue; Kaoru Kumata; Yoshiaki Usui (+4 著者) Masami Takeuchi
HEMATOLOGICAL ONCOLOGY 35: 323 (2017) Semantic Scholar
48. Whole-body computed tomography versus conventional skeletal survey in patients with multiple myeloma: a study of the International Myeloma Working Group J. Hillengass; L. A. Moulopoulos; S. Delorme; V. Koutoulidis (+17 著者) E. Terpos
BLOOD CANCER JOURNAL 7: (2017) Semantic Scholar
49. 原発性中枢神経系リンパ腫(PCNSL)の標的化サイレンシング(Targeted sequencing of primary central nervous system lymphoma(PCNSL)) 服部圭一朗; 坂田麻実子[柳元]; 末原泰人; 横山泰久 (+4 著者) 千葉滋
日本リンパ網内系学会会誌 57: 95 (2017)
50. Abnormal heavy/light chain ratio after treatment is associated with shorter survival in patients with IgA myeloma Yasuhito Suehara; Hiroyuki Takamatsu; Kota Fukumoto; Manabu Fujisawa (+4 著者) Kosei Matsue
CANCER SCIENCE 108: 187 (2017) Semantic Scholar
51. Prognostic impact of immunophenotypic complete response in patients with multiple myeloma achieving better than complete response Fukumoto, K.; Fujisawa, M.; Suehara, Y.; Narita, K.-T. (+2 著者) Matsue, K.
Leukemia and Lymphoma 57: (2016) Semantic Scholar
52. Clinical features and treatment outcome of very elderly patients over 80 years old with multiple myeloma: comparison with patients in different age groups in the era of novel agents Kosei Matsue; Yuya Matsue; Manabu Fujisawa; Kota Fukumoto (+2 著者) Masami Takeuchi
LEUKEMIA & LYMPHOMA 57: 110 (2016) Semantic Scholar
53. Changes in survival rate of multiple myeloma after the introduction of bortezomib: a single institutional experience over 20 years Manabu Fujisawa; Yasuhito Suehara; Kota Fukumoto; Masami TakeuchiKosei Matsue
ANNALS OF HEMATOLOGY 95: 63 (2016) Semantic Scholar
54. Clinical and prognostic significance of bone marrow abnormalities in the appendicular skeleton detected by low-dose whole-body multidetector computed tomography in patients with multiple myeloma Y. Nishida; Y. Matsue; Y. Suehara; K. Fukumoto (+3 著者) K. Matsue
BLOOD CANCER JOURNAL 5: (2015) Semantic Scholar
55. Oligoclonal bands in patients with multiple myeloma: Its emergence per se could not be translated to improved survival Manabu Fujisawa; Keisuke Seike; Kouta Fukumoto; Yasuhito Suehara (+3 著者) Kosei Matsue
CANCER SCIENCE 105: 1442 (2014) Semantic Scholar
56. Percentage of urinary albumin excretion and serum-free light-chain reduction are important determinants of renal response in myeloma patients with moderate to severe renal impairment H. Sugihara; D. Chihara; K. Seike; K. Fukumoto (+4 著者) K. Matsue
BLOOD CANCER JOURNAL 4: (2014) Semantic Scholar

« 1 2 3

1. EBM血液疾患の治療坂田(柳元)麻実子, 槇島健一, 末原泰人. (担当:分担執筆, 範囲:Topics: リンパ腫病型とゲノム異常)
中外医学社 2022年10月 (ISBN: 9784498225404)
2. がんゲノム医療結果報告書の読み方と患者への伝え方 : エキスパートパネルの実際末原泰人; 服部圭一朗; 千葉滋 (担当:分担執筆, 範囲:第7章シーケンスデータの品質の指標と変異・CNVデータの読み方)
医学と看護社 2020年5月 (ISBN: 9784909888105)
3. プレシジョン・メディシン : ビッグデータの構築・分析から臨床応用・課題まで = Precision medicine 末原泰人; 日下部学; 坂田(柳元), 麻実子; 千葉, 滋 (担当:分担執筆, 範囲:分担執筆, 範囲:第2編第2章第5節血液がんの変異遺伝子を標的とした個別化治療への応用－血液がんにおけるPRECISION MEDICINE-)
エヌ・ティー・エス 2018年 (ISBN: 9784860435806)

講演・口頭発表情報はまだありません。

知財情報はまだありません。

230 total views

末原泰人

SUEHARA, Yasuhito

この研究者の他の情報源

キーワードが似ている研究者

この研究者の情報を共有